A detailed history of Fc Advisory LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fc Advisory LLC holds 1,647 shares of LLY stock, worth $1.49 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
1,647
Previous 1,672 1.5%
Holding current value
$1.49 Million
Previous $1.3 Million 14.69%
% of portfolio
0.55%
Previous 0.48%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

SELL
$724.87 - $909.04 $18,121 - $22,726
-25 Reduced 1.5%
1,647 $1.49 Million
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $4,145 - $5,545
7 Added 0.42%
1,672 $1.3 Million
Q4 2021

Jan 04, 2022

SELL
$224.85 - $279.04 $3,147 - $3,906
-14 Reduced 0.83%
1,665 $460,000
Q4 2019

Jan 07, 2020

BUY
$106.92 - $132.43 $179,518 - $222,349
1,679 New
1,679 $222,000
Q2 2019

Jul 09, 2019

SELL
$110.79 - $129.32 $186,016 - $217,128
-1,679 Closed
0 $0
Q1 2019

Apr 08, 2019

BUY
$111.31 - $131.02 $186,889 - $219,982
1,679 New
1,679 $218,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fc Advisory LLC Portfolio

Follow Fc Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fc Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fc Advisory LLC with notifications on news.